|
Jun 24
|
Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
|
|
Feb 20
|
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
|
|
Feb 11
|
High Growth Tech And These 3 Dynamic Stocks with Promising Expansion
|
|
Feb 10
|
Pharming Group to participate in February investor conference
|
|
Oct 10
|
Pharming Group to report third quarter 2024 financial results on October 24
|
|
Feb 8
|
Pharming Group to participate in February investor conferences
|
|
Apr 26
|
Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023
|